$1b+
Raised to take university technology to market
150+
Active licence agreements
$70b+
Gross product sales of licensed
UQ technologies
$961m+
In revenue returned to UQ since 2002
125+
Companies created from our intellectual property portfolio
360+
Granted US patents
Impact highlights
Our commercialisation impact makes The University of Queensland Australia’s top university for licence income and value of equity held in spin-out companies.*
*National Survey of Research Commercialisation, Department of Industry, Innovation and Science, 2021
Gardasil®: A global solution to eradicating cervical cancer
The Gardasil® cervical cancer vaccine has led to a decrease of approximately 90 per cent in the prevalence of human papillomavirus (HPV), the major cause of cervical cancer.
UQ technology with the power to revolutionise global vaccine delivery
Vaxxas Pty Ltd is set to revolutionise vaccine delivery through its innovative High-Density Microarray Patch (HD-MAP).
Encapsulated probiotic drink a world first
The world’s first encapsulated probiotic drink uses patented micro-shield technology to deliver targeted in-gut release of effective probiotics.
A smartphone app helping doctors and patients breathe easier
Just one cough and a simple and inexpensive new smartphone technology can instantly and accurately identify respiratory diseases.
Bringing the benefits of positive parenting to the world
The Triple P-Positive Parenting Program is changing the lives of millions of families around the world and helping to build stronger, more resilient communities.
MRI scan technology is savings lives around the world
UQ’s innovative technology, which is used in most of the world’s MRI machines, has helped more than 8 billion people across the globe.
Contact our team
UniQuest has access to over 7000+ UQ researchers with research at or above world standard across 30 research strength areas.